ACONITUM NAPELLUS

N/A

Manufactured by BM Private Limited

Last updated: 2026-04-15

About ACONITUM NAPELLUS

ACONITUM NAPELLUS is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BM Private Limited. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ACONITUM NAPELLUS.

Demographics Breakdown

Reports by Age

Age 807 reports
Age 736 reports
Age 775 reports
Age 574 reports
Age 614 reports
Age 714 reports
Age 223 reports
Age 783 reports
Age 813 reports
Age 292 reports
Age 412 reports
Age 422 reports
Age 432 reports
Age 552 reports
Age 592 reports
Age 672 reports
Age 682 reports
Age 862 reports
Age 251 reports
Age 281 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

Who manufactures ACONITUM NAPELLUS?

Labeling and FAERS entries often list BM Private Limited in connection with ACONITUM NAPELLUS. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.